PMI Submits PMTA for IQOS ILUMA Heated Tobacco Product
According to a report by Yahoo Finance on October 20, Philip Morris International (PMI) has submitted a Pre-Market Tobacco Product Application (PMTA) and a Modified Risk Tobacco Product Application (MRTPA) to the US Food and Drug Administration (FDA) for its IQOS ILUMA heated tobacco product.
In order to sell their new tobacco products in the United States, PMI needs to obtain PMTA approval. The company is also seeking permission to market the IQOS ILUMA product as an improved risk product that reduces exposure to harmful and potentially harmful chemicals, just like the previous versions of IQOS which were granted this status.
The following are the key details released by PMI:
Unlike traditional cigarettes, IQOS products heat but do not burn tobacco. The IQOS ILUMA product is the most innovative heated tobacco product from PMI. In comparison to the previously FDA authorized versions of IQOS, they show a significant reduction in the formation of harmful and potentially harmful constituents. IQOS ILUMA demonstrates higher overall conversion rates and improved consumer satisfaction among adult smokers in various countries worldwide. This product relies on a completely different heating technology from previous versions of IQOS and includes several technological advancements, such as improved device and battery life. IQOS ILUMA is currently available in 27 international markets. PMI's application is supported by thorough scientific evaluations, including aerosol chemistry, in vitro toxicology, pharmacokinetic studies, consumer perception and behavior research, and comprehensive scientific data collected from the previous version of the IQOS system. The IQOS ILUMA device operates on the SMARTCORE induction system, which internally heats tobacco through the use of TEREA SMARTCORE pods designed exclusively for use with the IQOS ILUMA device. PMI has submitted applications for three ILUMA devices and five pods: TEREA BLUE, TEREA GREEN, TEREA SIENNA, TEREA BRONZE, and TEREA AMBER.
Disclaimer:
This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.
